Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infection.
about
Manipulation of the host protein acetylation network by human immunodeficiency virus type 1An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patientsActivation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapyHIVed, a knowledgebase for differentially expressed human genes and proteins during HIV infection, replication and latency.Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatmentStochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc.Is the central nervous system a reservoir of HIV-1?A real time PCR platform for the simultaneous quantification of total and extrachromosomal HIV DNA forms in blood of HIV-1 infected patientsMyeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells.Autophagy induction by histone deacetylase inhibitors inhibits HIV type 1.Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disordersLEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIVHIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.How to best measure HIV reservoirs?GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals.A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals.The Use of Ultra-Sensitive Molecular Assays in HIV Cure-Related Research.Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.
P2860
Q26795463-19935754-885D-4E13-8825-29B2CE56D7EAQ28538015-65D64EB8-56A5-43A0-96CC-C0521D9BFE75Q28544949-8C7904E5-EDC4-46C3-87B3-ECE8753B43EAQ30400491-BE589EA8-D175-4798-A7FD-3B56F5F934AFQ33925025-41F6A409-A07F-41E0-8D9E-B4F61D4CF3C6Q34367158-A4C20B49-78DD-489D-AD4C-45BACBAD5CF8Q34434339-EF7F6711-CF11-43B1-9F3C-BCE9EC82103EQ34446014-F5650CEA-078A-4805-A509-20DA27A0FD07Q35067224-D16B9D70-874E-4447-8FEA-ADAA9E8ABD59Q35103991-169BAD67-41C8-4548-A8A1-B017B69A5F7BQ35549754-8C4BD9C3-5053-46B8-A223-4ABC8B3B37FDQ36068841-0DEC9A28-5F21-40CA-9FFE-42469F04F1D2Q36868552-67181601-223C-46CC-8F9A-287A29EC215EQ37035177-774B0346-2AAF-4232-A0B0-D57E4ECDFE42Q37129639-AF784DE2-28B2-4EA9-B3D4-4BD1F38C0D61Q37149147-74265EB0-15D6-449A-AA01-66B5766724E8Q37335823-C58ADBD0-DA2A-4C5A-BD8D-A0794519AA0FQ40270401-7384C3D6-BEF2-4A07-8C81-293045A8092DQ41722884-0D2F75C6-EFF2-4573-84B3-688E021DB04EQ42037424-99DE2D23-10B4-4139-B1A8-70AE3F1161FFQ42130441-C6DF84E1-E804-4A6E-A59C-624D07866B4FQ55255033-8678BAF5-972E-4396-B439-96471593BE03
P2860
Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Virologic determinants of succ ...... rals in acute HIV-1 infection.
@en
Virologic determinants of succ ...... rals in acute HIV-1 infection.
@nl
type
label
Virologic determinants of succ ...... rals in acute HIV-1 infection.
@en
Virologic determinants of succ ...... rals in acute HIV-1 infection.
@nl
prefLabel
Virologic determinants of succ ...... rals in acute HIV-1 infection.
@en
Virologic determinants of succ ...... rals in acute HIV-1 infection.
@nl
P2093
P50
P1476
Virologic determinants of succ ...... irals in acute HIV-1 infection
@en
P2093
Ajantha Solomon
Anthony D Kelleher
Damian J Purcell
David A Cooper
John J Zaunders
Mark Bloch
P304
P356
10.1097/QAI.0B013E31815DBF7F
P407
P577
2008-02-01T00:00:00Z